Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
WGS
#1576
GeneDx Holdings Corp. Class A Common Stock
79.7
1
+0.35%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+0.35%
Aylık değişim
-16.98%
6 aylık değişim
-37.42%
Yıllık değişim
-21.08%
Önceki kapanış
79.4
3
Open
79.7
1
Bid
Ask
Low
79.7
1
High
79.7
1
Hacim
69
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
WGS
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Haberler
GeneDx: The Growth Story Isn't Dead, It's Changing (Rating Upgrade) (NASDAQ:WGS)
These Analysts Slash Their Forecasts On GeneDx After Q4 Results - GeneDx Holdings (NASDAQ:WGS)
BTIG senkt Kursziel für GeneDx aufgrund verzögerter Wachstumsaussichten
BTIG cuts GeneDx stock price target on back-end loaded growth outlook
GeneDx Holdings Corp. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:WGS) 2026-02-23
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
GeneDx Q4 2025: Umsatzplus von 54 % und aggressive Expansionspläne für 2026
GeneDx Q4 2025 slides: 54% revenue growth, aggressive 2026 expansion
Canaccord Genuity bestätigt Kaufempfehlung für GeneDx und Kursziel von 170 US-Dollar
GeneDx: TD Cowen bestätigt Kaufempfehlung vor Quartalszahlen
GeneDx stock maintained at Buy by TD Cowen ahead of results call
Canaccord Genuity reiterates Buy on GeneDx stock, keeps $170 target